# Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

> **NCT04465162** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 75 (actual)

## Conditions studied

- Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- Extranodal Marginal Zone Lymphoma

## Interventions

- **OTHER:** Radiation Therapy

## Key facts

- **NCT ID:** NCT04465162
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06-07
- **Primary completion:** 2021-03-15
- **Final completion:** 2021-03-15
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2022-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04465162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04465162, "Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04465162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*